Q9KJA7 AF NFT

Metallo-beta-lactamase type 2

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeigfa46eu6zdlzwgmcqzqpq3bq5sihfkyqhqqx4px4wojxchnoke6i/metadata.json
IPFS of structure file: 
bafybeie7g5hgnyqw7ps2chfb53gx3lnuotogk27emncmfu7rc2zbt22d24/AF-Q9KJA7-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x42DcC00cE356900729440521AcEB4a4d706318cF
First NFT owner address (bech32): 
genesis1gtwvqr8r26gqw22yq5s6e662f4cxxxx0x0ntfx
Current NFT ID #44930 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
44930
Accession (UniProt):
Q9KJA7
Name::
Metallo-beta-lactamase type 2
Experimental Method:
Predicted structure
Sequence source:
ELIZABETHKINGIA MENINGOSEPTICA

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q9KJA7 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q9KJA7|BLAB8_ELIME Metallo-beta-lactamase type 2 OS=Elizabethkingia meningoseptica OX=238 GN=blaB8 PE=3 SV=1 MKGLKGLLVLALGFTGLQVFGQQNPDIKIEKLKDNLYVYTTYNTFKGTKYAANAVYMVTDKGVVVIDSPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKLGAKTYSTKMTDSILAKENKPRAKYTFDNNKSFKVGKTEFQVYYPGKGHTADNVVVWFPKDKVLVGGCIVKSGDSKDLGFIGEAYVNDWTQSIHNIQQKFPDVQYVVAGHDDWKDQTSIQHTLDLISEYQQKQKASN